|
Regulation of memory CD8 T cell development |
3R37AI066232-18S1 |
|
NIAID |
2022 |
|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
5R01AI141662-04 |
|
NIAID |
2022 |
|
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome |
5R01AI143710-04 |
|
NIAID |
2022 |
|
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome |
5R01AI145988-04 |
|
NIAID |
2022 |
|
Macrophage mitochodrial reprogramming and innate immune memory |
5R01AI151210-03 |
|
NIAID |
2022 |
|
Mediator kinases as interferon antagonists in Down Syndrome |
5R01AI156739-03 |
|
NIAID |
2022 |
|
The Impact of Maternal CMV Infection on Birth Outcomes |
5R03AI151426-02 |
|
NIAID |
2022 |
|
The effects of BTNL2 on experimental autoimmune encephalomyelitis |
5R21AI156779-02 |
|
NIAID |
2022 |
|
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome |
5R21AI161827-02 |
|
NIAID |
2022 |
|
Defining the Role of DNA Rereplication of Chromosome 21 in the Development and Pathophysiology of Down Syndrome |
1 R01 AI155918-01 |
BLACK, JOSHUA CRANSTON |
NIAID |
2021 |